Stay updated on SEA-CD70 Safety in Myeloid Malignancies Clinical Trial
Sign up to get notified when there's something new on the SEA-CD70 Safety in Myeloid Malignancies Clinical Trial page.

Latest updates to the SEA-CD70 Safety in Myeloid Malignancies Clinical Trial page
- ChecktodayChange DetectedA site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.SummaryDifference0.4%

- Check7 days agoChange DetectedThe ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedThe history now includes a new Revision: v3.7.0 entry, replacing the previous Revision: v3.6.6. This reflects an underlying platform update to the page history interface rather than changes to the study record content.SummaryDifference0.1%

- Check42 days agoChange DetectedEnrollment status is now Active, not recruiting, and core sections describing the arms, design, and contact details were added or updated. This signals a transition in the study documentation and alignment with the new status.SummaryDifference0.7%

- Check56 days agoChange DetectedA new revision number, v3.6.6, appears on the page, updating the record's version in the history. This reflects an internal update to the page rather than any substantive changes to study data.SummaryDifference0.1%

Stay in the know with updates to SEA-CD70 Safety in Myeloid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SEA-CD70 Safety in Myeloid Malignancies Clinical Trial page.